Episode

5181: From Make in India to Global Impact: India’s MedTech Future | Wipro GE Healthcare

Podcast
Moneycontrol Podcast
Published
May 26, 2026
Duration seconds
1257
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8907844
Audio
https://audioboom.com/posts/8907844.mp3?modified=1779781887&sid=4937727&source=rss
JSON
/v1/public/podcasts/moneycontrol-podcast-471941/episodes/5181-from-make-in-india-to-global-impact-india-s-medtech-future-wipro-ge-healthcare
Markdown
/podcast/moneycontrol-podcast-471941/5181-from-make-in-india-to-global-impact-india-s-medtech-future-wipro-ge-healthcare.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/moneycontrol-podcast-471941/episodes/5181-from-make-in-india-to-global-impact-india-s-medtech-future-wipro-ge-healthcare/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/moneycontrol-podcast-471941/5181-from-make-in-india-to-global-impact-india-s-medtech-future-wipro-ge-healthcare.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

India’s medical devices industry is entering a high‑growth phase, with the market set to expand from USD 14 billion today to nearly USD 30 billion by 2030. With India ranking among the top 20 MedTech markets globally, the healthcare ecosystem is taking several steps and initiatives that are steering the country toward sustained growth in the sector. In this episode, we are joined by Raghavendra Rao, Chief Operating Officer – Distribution, Wipro GE Healthcare, who highlights that demand, a supportive public‑policy environment, and the shift from reactive care to early prediction are three key pillars that will drive India’s MedTech opportunity. He also reflects on the company’s journey of ‘Make in India, for India, and for the World’ and how GE HealthCare plans to build on this momentum going forward.